Similar articles

• An autopsy case of acute pulmonary toxicity associated with gemcitabine.

  Maniwa K, Tanaka E, Inoue T, Kato T, Sakuramoto M, Minakuchi M, Maeda Y, Noma S, Kobashi Y, Taguchi Y. Maniwa K, et al. Intern Med. 2003 Oct;42(10):1022-5. doi: 10.2169/internalmedicine.42.1022. Intern Med. 2003. PMID: 14606719 Review.
• [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].

  Dahan L, Ressiot E, Cournede A, Ries P, Duluc M, Laquiere A, Laugier R, Braguer D, Seitz JF. Dahan L, et al. Gastroenterol Clin Biol. 2007 Dec;31(12):1143-5. doi: 10.1016/s0399-8320(07)78353-7. Gastroenterol Clin Biol. 2007. PMID: 18176375 French.
• Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.

  Sawai H, Okada Y, Tanaka M, Funahashi H, Yamamoto M, Takeyama H, Manabe T. Sawai H, et al. Dig Dis Sci. 2006 Jul;51(7):1285-9. doi: 10.1007/s10620-006-8050-7. Dig Dis Sci. 2006. PMID: 16944027 No abstract available.
• [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].

  Bonnichon A, Vedrine L, Aletti M, Le Moulec S, Borne M, Margery J, Bauduceau O, Fayolle M, Ceccaldi B. Bonnichon A, et al. Rev Pneumol Clin. 2007 Dec;63(6):379-83. doi: 10.1016/s0761-8417(07)78425-0. Rev Pneumol Clin. 2007. PMID: 18166944 French.
• Safety of capecitabine use in patients with liver dysfunction.

  Saif MW, Tejani MA. Saif MW, et al. Clin Adv Hematol Oncol. 2007 Sep;5(9):730-2; discussion 736. Clin Adv Hematol Oncol. 2007. PMID: 17982413 Review. No abstract available.